Co-Authors
This is a "connection" page, showing publications co-authored by RICHARD GIBBS and KIMBERLY WALKER.
Connection Strength
0.926
-
Double Mosaicism in Xia-Gibbs Syndrome. Am J Med Genet A. 2026 Jul; 200(7):1657-1661.
Score: 0.241
-
Multi-Omics Characterization of Human Molecular Responses to Spaceflight Across Two Independent Missions. bioRxiv. 2026 Jun 04.
Score: 0.061
-
An integrated cardiometabolic genetic testing program in a predominantly Hispanic population within a community setting. Genet Med. 2026 Jul; 28(7):102595.
Score: 0.061
-
Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read data. bioRxiv. 2025 Oct 14.
Score: 0.059
-
Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
Score: 0.058
-
Celeste: A cloud-based genomics infrastructure with variant-calling pipeline suited for population-scale sequencing projects. medRxiv. 2025 Apr 30.
Score: 0.057
-
Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024 Sep 16.
Score: 0.055
-
Author Correction: The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun Biol. 2024 Jun 10; 7(1):713.
Score: 0.054
-
The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun Biol. 2024 02 19; 7(1):174.
Score: 0.052
-
Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program. Genome Med. 2022 03 28; 14(1):34.
Score: 0.046
-
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022 05; 24(5):1062-1072.
Score: 0.046
-
Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol). Int J Epidemiol. 2020 02 01; 49(1):23-24k.
Score: 0.040
-
Megabase Length Hypermutation Accompanies Human Structural Variation at 17p11.2. Cell. 2019 03 07; 176(6):1310-1324.e10.
Score: 0.037
-
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016 Feb 02; 14(4):907-919.
Score: 0.030
-
Hutterite-type cataract maps to chromosome 6p21.32-p21.31, cosegregates with a homozygous mutation in LEMD2, and is associated with sudden cardiac death. Mol Genet Genomic Med. 2016 Jan; 4(1):77-94.
Score: 0.030